Global Oncolytic Virus Market Growth 2020-2025
According to this study, over the next five years the Oncolytic Virus market will register a 7.1%% CAGR in terms of revenue, the global market size will reach $ 20 million by 2025, from $ 15 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oncolytic Virus business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Oncolytic Virus, covering the supply chain analysis, impact assessment to the Oncolytic Virus market size growth rate in several scenarios, and the measures to be undertaken by Oncolytic Virus companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Imlygic
Oncorine
Others
Imlygic is the most widely used type which takes up about 85% of the total market share in 2019.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Melanoma
Other Cancers
The application of oncolytic virus therapy includes melanoma and other cancer, and the proportion of sales for melanoma in 2018 is about 85.52%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
Shanghai Sunway Biotech
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Oncolytic Virus consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Oncolytic Virus market by identifying its various subsegments.
Focuses on the key global Oncolytic Virus manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncolytic Virus with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oncolytic Virus submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Consumption 2015-2025
2.1.2 Oncolytic Virus Consumption CAGR by Region
2.2 Oncolytic Virus Segment by Type
2.2.1 Imlygic
2.2.2 Oncorine
2.2.3 Others
2.3 Oncolytic Virus Consumption by Type
2.3.1 Global Oncolytic Virus Consumption Market Share by Type (2015-2020)
2.3.2 Global Oncolytic Virus Revenue and Market Share by Type (2015-2020)
2.3.3 Global Oncolytic Virus Sale Price by Type (2015-2020)
2.4 Oncolytic Virus Segment by Application
2.4.1 Melanoma
2.4.2 Other Cancers
2.5 Oncolytic Virus Consumption by Application
2.5.1 Global Oncolytic Virus Consumption Market Share by Type (2015-2020)
2.5.2 Global Oncolytic Virus Value and Market Share by Type (2015-2020)
2.5.3 Global Oncolytic Virus Sale Price by Type (2015-2020)
3 Global Oncolytic Virus by Company
3.1 Global Oncolytic Virus Sales Market Share by Company
3.1.1 Global Oncolytic Virus Sales by Company (2018-2020)
3.1.2 Global Oncolytic Virus Sales Market Share by Company (2018-2020)
3.2 Global Oncolytic Virus Revenue Market Share by Company
3.2.1 Global Oncolytic Virus Revenue by Company (2018-2020)
3.2.2 Global Oncolytic Virus Revenue Market Share by Company (2018-2020)
3.3 Global Oncolytic Virus Sale Price by Company
3.4 Global Oncolytic Virus Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Oncolytic Virus Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Oncolytic Virus Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Oncolytic Virus by Regions
4.1 Oncolytic Virus by Regions
4.2 Americas Oncolytic Virus Consumption Growth
4.3 APAC Oncolytic Virus Consumption Growth
4.4 Europe Oncolytic Virus Consumption Growth
4.5 Middle East & Africa Oncolytic Virus Consumption Growth
5 Americas
5.1 Americas Oncolytic Virus Consumption by Countries
5.1.1 Americas Oncolytic Virus Consumption by Countries (2015-2020)
5.1.2 Americas Oncolytic Virus Value by Countries (2015-2020)
5.2 Americas Oncolytic Virus Consumption by Type
5.3 Americas Oncolytic Virus Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Oncolytic Virus Consumption by Regions
6.1.1 APAC Oncolytic Virus Consumption by Regions (2015-2020)
6.1.2 APAC Oncolytic Virus Value by Regions (2015-2020)
6.2 APAC Oncolytic Virus Consumption by Type
6.3 APAC Oncolytic Virus Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Oncolytic Virus by Countries
7.1.1 Europe Oncolytic Virus Consumption by Countries (2015-2020)
7.1.2 Europe Oncolytic Virus Value by Countries (2015-2020)
7.2 Europe Oncolytic Virus Consumption by Type
7.3 Europe Oncolytic Virus Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Oncolytic Virus by Countries
8.1.1 Middle East & Africa Oncolytic Virus Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Oncolytic Virus Value by Countries (2015-2020)
8.2 Middle East & Africa Oncolytic Virus Consumption by Type
8.3 Middle East & Africa Oncolytic Virus Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oncolytic Virus Distributors
10.3 Oncolytic Virus Customer
11 Global Oncolytic Virus Market Forecast
11.1 Global Oncolytic Virus Consumption Forecast (2021-2025)
11.2 Global Oncolytic Virus Forecast by Regions
11.2.1 Global Oncolytic Virus Forecast by Regions (2021-2025)
11.2.2 Global Oncolytic Virus Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oncolytic Virus Forecast by Type
11.8 Global Oncolytic Virus Forecast by Application
12 Key Players Analysis
12.1 Amgen
12.1.1 Company Information
12.1.2 Oncolytic Virus Product Offered
12.1.3 Amgen Oncolytic Virus Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Amgen Latest Developments
12.2 Shanghai Sunway Biotech
12.2.1 Company Information
12.2.2 Oncolytic Virus Product Offered
12.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shanghai Sunway Biotech Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Oncolytic Virus Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Imlygic
Table 5. Major Players of Oncorine
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Oncolytic Virus Consumption Market Share by Type (2015-2020)
Table 9. Global Oncolytic Virus Revenue by Type (2015-2020) ($ million)
Table 10. Global Oncolytic Virus Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Oncolytic Virus Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Oncolytic Virus Consumption Market Share by Application (2015-2020)
Table 14. Global Oncolytic Virus Value by Application (2015-2020)
Table 15. Global Oncolytic Virus Value Market Share by Application (2015-2020)
Table 16. Global Oncolytic Virus Sale Price by Application (2015-2020)
Table 17. Global Oncolytic Virus Sales by Company (2017-2019) (K Units)
Table 18. Global Oncolytic Virus Sales Market Share by Company (2017-2019)
Table 19. Global Oncolytic Virus Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Oncolytic Virus Revenue Market Share by Company (2017-2019)
Table 21. Global Oncolytic Virus Sale Price by Company (2017-2019)
Table 22. Global Oncolytic Virus Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Oncolytic Virus Products Offered
Table 24. Oncolytic Virus Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Oncolytic Virus Consumption by Regions 2015-2020 (K Units)
Table 26. Global Oncolytic Virus Consumption Market Share by Regions 2015-2020
Table 27. Global Oncolytic Virus Value by Regions 2015-2020 ($ Millions)
Table 28. Global Oncolytic Virus Value Market Share by Regions 2015-2020
Table 29. Americas Oncolytic Virus Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Oncolytic Virus Consumption Market Share by Countries (2015-2020)
Table 31. Americas Oncolytic Virus Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Oncolytic Virus Value Market Share by Countries (2015-2020)
Table 33. Americas Oncolytic Virus Consumption by Type (2015-2020) (K Units)
Table 34. Americas Oncolytic Virus Consumption Market Share by Type (2015-2020)
Table 35. Americas Oncolytic Virus Consumption by Application (2015-2020) (K Units)
Table 36. Americas Oncolytic Virus Consumption Market Share by Application (2015-2020)
Table 37. APAC Oncolytic Virus Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Oncolytic Virus Consumption Market Share by Countries (2015-2020)
Table 39. APAC Oncolytic Virus Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Oncolytic Virus Value Market Share by Regions (2015-2020)
Table 41. APAC Oncolytic Virus Consumption by Type (2015-2020) (K Units)
Table 42. APAC Oncolytic Virus Consumption Market Share by Type (2015-2020)
Table 43. APAC Oncolytic Virus Consumption by Application (2015-2020) (K Units)
Table 44. APAC Oncolytic Virus Consumption Market Share by Application (2015-2020)
Table 45. Europe Oncolytic Virus Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Oncolytic Virus Consumption Market Share by Countries (2015-2020)
Table 47. Europe Oncolytic Virus Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Oncolytic Virus Value Market Share by Countries (2015-2020)
Table 49. Europe Oncolytic Virus Consumption by Type (2015-2020) (K Units)
Table 50. Europe Oncolytic Virus Consumption Market Share by Type (2015-2020)
Table 51. Europe Oncolytic Virus Consumption by Application (2015-2020) (K Units)
Table 52. Europe Oncolytic Virus Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Oncolytic Virus Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Oncolytic Virus Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Oncolytic Virus Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Oncolytic Virus Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Oncolytic Virus Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Oncolytic Virus Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Oncolytic Virus Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Oncolytic Virus Consumption Market Share by Application (2015-2020)
Table 61. Oncolytic Virus Distributors List
Table 62. Oncolytic Virus Customer List
Table 63. Global Oncolytic Virus Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Oncolytic Virus Consumption Market Forecast by Regions
Table 65. Global Oncolytic Virus Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Oncolytic Virus Value Market Share Forecast by Regions
Table 67. Global Oncolytic Virus Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Oncolytic Virus Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Oncolytic Virus Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Oncolytic Virus Value Market Share Forecast by Type (2021-2025)
Table 71. Global Oncolytic Virus Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Oncolytic Virus Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Oncolytic Virus Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Oncolytic Virus Value Market Share Forecast by Application (2021-2025)
Table 75. Amgen Product Offered
Table 76. Amgen Oncolytic Virus Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. Amgen Main Business
Table 78. Amgen Latest Developments
Table 79. Amgen Basic Information, Company Total Revenue (in $ million), Oncolytic Virus Manufacturing Base, Sales Area and Its Competitors
Table 80. Shanghai Sunway Biotech Product Offered
Table 81. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Shanghai Sunway Biotech Main Business
Table 83. Shanghai Sunway Biotech Latest Developments
Table 84. Shanghai Sunway Biotech Basic Information, Company Total Revenue (in $ million), Oncolytic Virus Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Oncolytic Virus
Figure 2. Oncolytic Virus Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Oncolytic Virus Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Oncolytic Virus Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Imlygic
Figure 7. Product Picture of Oncorine
Figure 8. Product Picture of Others
Figure 9. Global Oncolytic Virus Consumption Market Share by Type (2015-2020)
Figure 10. Global Oncolytic Virus Value Market Share by Type (2015-2020)
Figure 11. Oncolytic Virus Consumed in Melanoma
Figure 12. Global Oncolytic Virus Market: Melanoma (2015-2020) (K Units)
Figure 13. Global Oncolytic Virus Market: Melanoma (2015-2020) ($ Millions)
Figure 14. Oncolytic Virus Consumed in Other Cancers
Figure 15. Global Oncolytic Virus Market: Other Cancers (2015-2020) (K Units)
Figure 16. Global Oncolytic Virus Market: Other Cancers (2015-2020) ($ Millions)
Figure 17. Global Oncolytic Virus Consumption Market Share by Application (2015-2020)
Figure 18. Global Oncolytic Virus Value Market Share by Application (2015-2020)
Figure 19. Global Oncolytic Virus Sales Market Share by Company in 2017
Figure 20. Global Oncolytic Virus Sales Market Share by Company in 2019
Figure 21. Global Oncolytic Virus Revenue Market Share by Company in 2017
Figure 22. Global Oncolytic Virus Revenue Market Share by Company in 2019
Figure 23. Global Oncolytic Virus Sale Price by Company in 2019
Figure 24. Global Oncolytic Virus Consumption Market Share by Regions 2015-2020
Figure 25. Global Oncolytic Virus Value Market Share by Regions 2015-2020
Figure 26. Americas Oncolytic Virus Consumption 2015-2020 (K Units)
Figure 27. Americas Oncolytic Virus Value 2015-2020 ($ Millions)
Figure 28. APAC Oncolytic Virus Consumption 2015-2020 (K Units)
Figure 29. APAC Oncolytic Virus Value 2015-2020 ($ Millions)
Figure 30. Europe Oncolytic Virus Consumption 2015-2020 (K Units)
Figure 31. Europe Oncolytic Virus Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Oncolytic Virus Consumption 2015-2020 (K Units)
Figure 33. Middle East & Africa Oncolytic Virus Value 2015-2020 ($ Millions)
Figure 34. Americas Oncolytic Virus Consumption Market Share by Countries in 2019
Figure 35. Americas Oncolytic Virus Value Market Share by Countries in 2019
Figure 36. Americas Oncolytic Virus Consumption Market Share by Type in 2019
Figure 37. Americas Oncolytic Virus Consumption Market Share by Application in 2019
Figure 38. United States Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 39. United States Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 41. Canada Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 43. Mexico Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Oncolytic Virus Consumption Market Share by Countries in 2019
Figure 45. APAC Oncolytic Virus Value Market Share by Regions in 2019
Figure 46. APAC Oncolytic Virus Consumption Market Share by Type in 2019
Figure 47. APAC Oncolytic Virus Consumption Market Share by Application in 2019
Figure 48. China Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 49. China Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 51. Japan Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 53. Korea Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 55. Southeast Asia Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 56. India Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 57. India Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 59. Australia Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Oncolytic Virus Consumption Market Share by Countries in 2019
Figure 61. Europe Oncolytic Virus Value Market Share by Countries in 2019
Figure 62. Europe Oncolytic Virus Consumption Market Share by Type in 2019
Figure 63. Europe Oncolytic Virus Consumption Market Share by Application in 2019
Figure 64. Germany Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 65. Germany Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 66. France Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 67. France Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 68. UK Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 69. UK Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 71. Italy Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 73. Russia Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Oncolytic Virus Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Oncolytic Virus Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Oncolytic Virus Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Oncolytic Virus Consumption Market Share by Application in 2019
Figure 78. Egypt Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 79. Egypt Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 81. South Africa Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 83. Israel Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 85. Turkey Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Oncolytic Virus Consumption Growth 2015-2020 (K Units)
Figure 87. GCC Countries Oncolytic Virus Value Growth 2015-2020 ($ Millions)
Figure 88. Global Oncolytic Virus Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 89. Global Oncolytic Virus Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 91. Americas Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 92. APAC Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 93. APAC Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 94. Europe Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 95. Europe Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 97. Middle East & Africa Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 98. United States Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 99. United States Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 100. Canada Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 101. Canada Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 102. Mexico Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 103. Mexico Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 104. Brazil Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 105. Brazil Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 106. China Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 107. China Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 108. Japan Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 109. Japan Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 110. Korea Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 111. Korea Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 113. Southeast Asia Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 114. India Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 115. India Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 116. Australia Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 117. Australia Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 118. Germany Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 119. Germany Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 120. France Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 121. France Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 122. UK Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 123. UK Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 124. Italy Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 125. Italy Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 126. Russia Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 127. Russia Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 128. Spain Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 129. Spain Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 130. Egypt Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 131. Egypt Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 132. South Africa Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 133. South Africa Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 134. Israel Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 135. Israel Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 136. Turkey Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 137. Turkey Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Oncolytic Virus Consumption 2021-2025 (K Units)
Figure 139. GCC Countries Oncolytic Virus Value 2021-2025 ($ Millions)
Figure 140. Amgen Oncolytic Virus Market Share (2018-2020)
Figure 141. Shanghai Sunway Biotech Oncolytic Virus Market Share (2018-2020)
